Trial comparisons

curl "https://conductscience.org/api/comparisons/v1?page=241"

Response

The first 2 of this page's 20 results. GET /api/comparisons/v1?page=241

{
  "data": {
    "total": 85013,
    "results": [
      {
        "id": "NCT00363545-sae",
        "title": "Liquid Rotarix Group vs Lyophilized Rotarix Group: serious adverse events",
        "summary": "37 of 636 against 38 of 638; risk difference -0.1 points, 95% interval -2.8 to 2.5; NCT00363545, To Assess Immunogenicity, Reactogenicity & Safety of 2 Formulations of GSK's HRV Vaccine as 2-dose Vaccination (Infants)",
        "record": "/library/comparisons/NCT00363545-sae",
        "nct_id": "NCT00363545",
        "kind": "serious-adverse-events",
        "participants": 1274,
        "risk_difference": {
          "value": -0.001385027897714948,
          "lower": -0.02769950838529791,
          "upper": 0.024918780938716377
        },
        "group_1": "37 of 636",
        "group_2": "38 of 638",
        "difference": "-0.1 points",
        "interval": "-2.8 to 2.5",
        "trial_title": "To Assess Immunogenicity, Reactogenicity & Safety of 2 Formulations of GSK's HRV Vaccine as 2-dose Vaccination (Infants)"
      },
      {
        "id": "NCT00835003-sae",
        "title": "38 Weeks Group vs 39 Weeks Group: serious adverse events",
        "summary": "1 of 636 against 2 of 638; risk difference -0.2 points, 95% interval -1.0 to 0.6; NCT00835003, Timing of Planned Caesarean Section and Morbidity of the Newborn",
        "record": "/library/comparisons/NCT00835003-sae",
        "nct_id": "NCT00835003",
        "kind": "serious-adverse-events",
        "participants": 1274,
        "risk_difference": {
          "value": -0.0015624691942193567,
          "lower": -0.009886017334049422,
          "upper": 0.006064254992967399
        },
        "group_1": "1 of 636",
        "group_2": "2 of 638",
        "difference": "-0.2 points",
        "interval": "-1.0 to 0.6",
        "trial_title": "Timing of Planned Caesarean Section and Morbidity of the Newborn"
      }
    ],
    "no_events": 33758,
    "columns": [
      {
        "key": "title",
        "label": "Comparison"
      },
      {
        "key": "group_1",
        "label": "With the outcome",
        "under": "group_2"
      },
      {
        "key": "difference",
        "label": "Risk difference, 95% interval",
        "under": "interval"
      },
      {
        "key": "participants",
        "label": "Participants"
      },
      {
        "key": "nct_id",
        "label": "Trial",
        "under": "trial_title"
      }
    ],
    "order": "Most participants first",
    "kinds": {
      "all": 85013,
      "outcome": 33568,
      "serious-adverse-events": 31897,
      "deaths": 19548
    }
  },
  "release": "trial-comparisons-2026-03-23-0.1.0",
  "terms": [
    {
      "source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
      "license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "Freely available. Acknowledgement requested"
    },
    {
      "source": "ClinicalTrials.gov",
      "license": "none stated",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "No license stated"
    }
  ],
  "next": "/api/comparisons/v1?page=242",
  "request_id": "izWDh22KRAOGiFVT"
}